Abstract:Many epidemiological studies have explored the relationships between three genetic polymorphisms of genes encoding homocysteine-metabolizing enzymes (methionine synthase [MTR] A2756G, methionine synthase reductase [MTRR] A66G, and N-5,N-10-methylenetetrahydrofolate reductase [MTHFR] A1298C) and risk of coronary heart disease (CHD), but no conclusive results were obtained. Therefore, we performed a meta-analysis of 23 case-control studies. Odds ratio (OR) and 95% confidence interval (95% CI) were used to examine the strength of the associations. Among those primary studies, 22 studies were for Europeans, and one study focused on the MTR A2756G polymorphism in Asians. The results of combined analyses of the MTR A2756G polymorphism suggested that the G allele was associated with increased risk of CHD and myocardial infarction (MI) especially for Europeans (GG vs. AA for CHD: OR [95% CI] = 1.63 [1w.18-2.25], p(z-test) = 0.001, p(heterogeneity) = 0.274; GG + AG vs. AA for MI: OR [95% CI] = 1.44 [1.08-1.93], p(z-test) = 0.014, p(heterogeneity) = 0.611). In addition, the G allele was also associated with higher risk CHD based on population-based case-control studies (PCC) (GG vs. AA: OR [95% CI] = 1.75 [1.24-2.49], p(z-test) = 0.002, p(heterogeneity) = 0.316). The results suggested that the MTRR A66G polymorphism was not associated with risk of CHD for Europeans (AA vs. GG: OR [95% CI] = 1.07 [0.59- 1.94], p(z-test) = 0.831, p(heterogeneity) <0.01). The results suggested that the C allele of the MTHFR A1298C polymorphism might be associated with the increased risk of MI for Europeans (CC vs. CA + AA: OR [95% CI] = 1.37 [1.03-1.84], p(z-test) = 0.033, p(heterogeneity) = 0.668). However, when subgroup analyses for sources of controls were performed, conflicting results were obtained. The results suggested that the C allele was associated with decreased risk of CHD based on hospital-based case control studies, but associated with increased risk of CHD) based on PCC. This meta-analysis suggests that MTR A2756G polymorphism, but not MTRR A66G and MTHFR A1298C, is associated with risk of CHD for Europeans. Because of limitations and potential bias, more well-designed studies with larger sample size, especially focused on Asians and Africans, should be performed in the future.

Functional Variant in Methionine Synthase Reductase Intron-1 Significantly Increases the Risk of Congenital Heart Disease in the Han Chinese Population

Genetic variants reducing MTR gene expression increase the risk of congenital heart disease in Han Chinese populations.

Role of Methylenetetrahydrofolate Reductase 677C→T Polymorphism in the Development of Myocardial Infarction: Evidence from an Original Study and Updated Meta-Analysis

Mthfr C677t Polymorphism And Risk Of Congenital Heart Defects: Evidence From 29 Case-Control And Tdt Studies

Functional variant in methionine synthase reductase intron-1 is associated with pleiotropic congenital malformations

Genetic Variant In Mtrr, But Not Mtr, Is Associated With Risk Of Congenital Heart Disease: An Integrated Meta-Analysis

Associations of Common Variants in Methionine Metabolism Pathway Genes with Plasma Homocysteine and the Risk of Type 2 Diabetes in Han Chinese

Association of maternal methionine synthase reductase gene polymorphisms with the risk of congenital heart disease in offspring: a hospital-based case-control study

A Functional Variant in the Cystathionine Β-Synthase Gene Promoter Significantly Reduces Congenital Heart Disease Susceptibility in a Han Chinese Population

Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population.

Association of a MiR-499 SNP and risk of congenital heart disease in a Chinese population

Exome-Wide Association Study Identifies East Asian-Specific Missense Variant MTHFR C136T Influencing Homocysteine Levels in Chinese Populations RH: ExWAS of tHCY in a Chinese Population

The Human MTHFR Rs4846049 Polymorphism Increases Coronary Heart Disease Risk Through Modifying Mirna Binding.

A TBX5 3′UTR Variant Increases the Risk of Congenital Heart Disease in the Han Chinese Population

Association of MTR gene polymorphisms with the occurrence of non-syndromic congenital heart disease: a case–control study

Three genetic polymorphisms of homocysteine-metabolizing enzymes and risk of coronary heart disease: a meta-analysis based on 23 case-control studies.

A Genetic Variant in a Homocysteine Metabolic Gene That Increases the Risk of Congenital Cardiac Septal Defects in Han Chinese Populations

Association of Snps in Genes Involved in Folate Metabolism with the Risk of Congenital Heart Disease

Association Between Mthfr Polymorphisms and Congenital Heart Disease: A Meta-Analysis Based on 9,329 Cases and 15,076 Controls

Methylenetetrahydrofolate reductase C677T and reduced folate carrier 80 G>A polymorphisms are associated with an increased risk of conotruncal heart defects

Association Between the Polymorphism of Methylenetetrahydrofolate Reductase Gene C 677 T and Risks of Congenital Heart Disease : Meta-analysis of Case-control Study